» Articles » PMID: 18264752

Stimulant Injectors in Ukraine: the Next Wave of the Epidemic?

Overview
Journal AIDS Behav
Date 2008 Feb 12
PMID 18264752
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

This study was designed to assess differences in drug and sex-related risk behaviors between injectors of opiates only, opiate/sedative mix only and stimulants only. Participants were current out-of-treatment injection drug users (IDUs), unaware of their HIV status, recruited through street outreach in Kiev, Odessa and Makeevka/Donetsk, Ukraine. Overall, 22% tested positive for HIV, including 39% among opiate/sedative injectors, 19% among opiate injectors and 17% among stimulant injectors. Despite these differences, stimulant injectors were at higher risk than other IDUs in sharing a used needle/syringe, always injecting with others, injecting a drug solution drawn from a common container, having an IDU sex partner, not using condoms during vaginal or anal sex and on composite measures of injection and sex risks. After controlling for age differences, stimulant injectors remained at higher risk in their needle and sex risk behaviors. Without intervention, it is likely that HIV will increase among stimulant injectors.

Citing Articles

Reinfection rate of hepatitis C in HIV-1 positive men who have sex with men: A systematic review and meta-analysis.

Wan Z, Sun P, Dzakah E, Huang L, Shuai P, Liu Y Front Public Health. 2022; 10:855989.

PMID: 35968434 PMC: 9372531. DOI: 10.3389/fpubh.2022.855989.


Addressing injecting related risks among people who inject both opioids and stimulants: Findings from an Australian survey of people who inject drugs.

Brener L, Caruana T, Broady T, Cama E, Ezard N, Madden A Addict Behav Rep. 2022; 15:100398.

PMID: 35005190 PMC: 8717740. DOI: 10.1016/j.abrep.2021.100398.


Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy.

Akiyama M, Lipsey D, Heo M, Agyemang L, Norton B, Hidalgo J Clin Infect Dis. 2019; 70(12):2695-2702.

PMID: 31346609 PMC: 7456350. DOI: 10.1093/cid/ciz693.


HIV, Drug Injection, and Harm Reduction Trends in Eastern Europe and Central Asia: Implications for International and Domestic Policy.

LaMonaca K, Dumchev K, Dvoriak S, Azbel L, Morozova O, Altice F Curr Psychiatry Rep. 2019; 21(7):47.

PMID: 31161306 PMC: 6685549. DOI: 10.1007/s11920-019-1038-8.


Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis.

Tavitian-Exley I, Boily M, Heimer R, Uuskula A, Levina O, Maheu-Giroux M AIDS Behav. 2017; 22(4):1329-1340.

PMID: 28699018 PMC: 5878835. DOI: 10.1007/s10461-017-1836-0.